← Eichor
Condition: Human T Lymphotropic Virus 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human T Lymphotropic Virus 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Patients With HAM/TSP
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00001778Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Phase 1/Phase 2 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT04799288Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for
Phase 1 · 19 location(s) · National Cancer Institute (NCI) · NCT04301076A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
Phase 1/Phase 2 · 5 location(s) · Otsuka Medical Devices Co., Ltd. Japan · NCT07075328Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
Phase 2 · 1 location(s) · Carlos Brites · NCT07555431A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06698003
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.